# Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression

> **NCT01556100** · PHASE2 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 40 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** 18F-DTBZ AV-133

## Key facts

- **NCT ID:** NCT01556100
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2015-05
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01556100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01556100, "Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01556100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*